For founders who've built something real but haven't cracked the commercial side yet.
You have a product. Maybe some pilots. But founder-led sales has hit a wall, your positioning isn't landing, and you're not sure which path to market actually works. We help turn a great product into commercial traction, starting with clarity on who you're selling to, why they should care, and what path actually makes sense. Backed by 18+ years across healthcare, life sciences, and technology, learning what actually works.
If any of this sounds familiar, we should talk.
Primary fit: CEOs and founders at post-product health-tech, med-tech, and life sciences companies, typically seed to early Series A, who need to accelerate growth but don't have the commercial firepower in-house. Particularly deep in medical imaging, radiology AI, and clinical trials.
You get a partner who moves fast and works alongside your team, not from the sidelines.
Also a fit: European companies entering the US market. Med-tech consultancies turning services into products. Tech transfer offices navigating commercialization.
Every engagement is tailored to your specific challenge. We operate as impact partners with shared accountability, not consultants who prescribe frameworks and disappear. The focus is outcomes, not hours.
Deals that actually close. Full-cycle business development — identifying targets, hunting opportunities, qualifying leads, and managing the process to get agreements across the finish line. A deep network across therapeutics, devices, and digital health to accelerate conversations and open doors.
New revenue hiding in plain sight. Uncover adjacent opportunities, productize services, or launch new offerings. Find high-margin use cases in your existing capabilities — particularly for consultancies and service businesses ready to scale.
A roadmap from product to revenue. Design and execute market entry strategies — whether launching a new product, entering a new segment, or expanding internationally. Deep experience in US market entry for European health-tech and imaging AI companies.
For a structured 4-6 week engagement with defined deliverables, see the GTM Accelerator.
The foundation that makes everything else work. Pressure-test your value proposition, sharpen your messaging, and align your product to what the market actually wants to buy. Clear positioning turns conversations into closed deals — especially in complex spaces like medical imaging and radiology AI.
Senior commercial leadership without a full-time hire. Step into CBO, VP BD, or similar roles on a fractional basis. Full integration with your team — operating and executing, not just advising.
From lab to market. Support for tech transfer offices, university ventures, and incubators — including technology evaluation, commercialization roadmaps, and buyer-ready materials that resonate with corporate BD teams and investors.
A few examples of recent engagements (details anonymized for confidentiality):
Challenge
Transform a services-heavy business into a scalable, AI-native product company while protecting existing revenue.
What We Did
Outcome
Margins improved by 40%. SaaS product launched in record time. Business now has three distinct revenue streams with improved scalability.
Challenge
Enter the US market with limited resources, unclear product-market fit, and no local presence.
What We Did
Outcome
12+ qualified partnership conversations in first 4 months. First pilot launched within 6 months and converted to paid customer. Three additional pilots pending.
Challenge
Strong technology but unclear value proposition for the life sciences segment.
What We Did
Outcome
Sharper go-to-market messaging; improved sales conversations.
Challenge
A university tech transfer office had a promising theranostic imaging technology but unclear commercial pathways in a change-resistant industry.
What We Did
Outcome
University team received clear basis for investment decisions. Two high-priority applications identified with defined adoption pathway.
I started as a scientist. MS in machine learning, PhD in medical imaging, years in the lab running multi-modality preclinical imaging studies for pharma. I liked the science, but I kept asking different questions: why does this technology matter to anyone outside this building? Who is going to buy it? How?
I transitioned to a business development role at a med device company. That led to seven years in management consulting, advising Fortune 500 healthcare companies spanning payers, pharma/life sciences, and med-device on innovation strategy. I learned frameworks like jobs-to-be-done and lean startup, but more importantly I learned how companies actually make decisions, what holds them back, and how they could apply principles of innovation to be more nimble and find market success.
I then spent several years at mid to late stage SaaS and med-tech startups. I have led customer success teams, built strategic partnerships, and built sales and BD motions from the ground up. Eighteen years total, mostly spent figuring out how to take innovations to market and build strong revenue streams.
Today I work with health-tech founders who have strong technology but need help on the commercial side. Recent engagements include transforming a clinical trials consultancy into an AI-native product company, leading US market entry for a European radiology AI startup and advising a university tech transfer office on imaging technology commercialization.
"Technical founders don't need someone to explain their technology back to them. They need someone who can translate it into a commercial story that resonates with buyers."
Vinny helped us go from a vague idea to a real go-to-market strategy in weeks, not months. His combination of technical credibility and commercial instincts is rare.
We brought Vinny in as a fractional CBO and he operated like a true member of the team. He didn't just advise — he executed. The partnership he closed changed our business trajectory.
What impressed me most was how quickly Vinny understood our technology and translated it into language the market cares about. Our positioning is dramatically sharper now.
* Testimonials are representative of client feedback. Names withheld for confidentiality.
Thoughts on growth, partnerships, and building in health-tech.
Most professionals are still using AI the way they used ChatGPT in 2023. Type a question, get a summary, go back to their spreadsheet. A smaller group has moved into something fundamentally different: building agentic systems that execute multi-step workflows autonomously. The gap is compounding every month.
Dario Amodei said AI 'has gotten better than radiologists at doing scans.' Jensen Huang argued AI creates radiology jobs, not destroys them. Both got it partly right, partly wrong. The truth sits between the hype and the dismissal: AI won't replace radiologists this decade, but the nature of the work is shifting.
One year into building my own advisory practice, I confront an uncomfortable truth: AI has commoditized most expert knowledge. So what's actually left to sell?
If you're working on a growth challenge and think I might be able to help, I'd love to hear from you. No pitch, no pressure — just a conversation to see if there's a fit.
Prefer LinkedIn?
Connect with meThanks for reaching out. We will be in touch soon.
